Faculty Support

New Treatments For Asthma

“...the most exciting discovery that I’ve been involved with.”

“...the most exciting discovery that I’ve been involved with.”

Associate professor of medicine Robert Tarran is a leader in cystic fibrosis and chronic obstructive pulmonary disease research. After identifying a specific protein in that work, Tarran’s colleague Steve Tilley, an associate professor of medicine, wondered what role it might play in his own research.

The result of that curiosity is what Tilley called “…the most exciting discovery that I’ve been involved with” and a potential for new, more effective treatments for the more than 334 million worldwide who suffer from asthma.

“The cost of asthma to the healthcare system in the U.S. is quite big,” Tarran said. “Most of the asthma therapies people use are inhalers, which have been around for decades. This protein could be a potentially new target to go after, and it could really benefit a lot of people.”

Read the complete Carolina Story from UNC Health Care…Opens in new window

This is story number 102 in the Carolina Stories 225th Anniversary Edition magazine.

The study was funded by the American Asthma Association and the National Institutes of Health.

 

UNC Medicine Funding Priorities

Explore More Stories

Sciences

A scientific gamechanger

Editing along ethical boundaries

Health

Protecting Pediatric Patients

Creating pediatric masks for UNC Health

Jessica Lin
Research

Addressing the COVID-19 infection rate of household members

A study led by Jessica Lin, an infectious disease researcher at UNC, is addressing the COVID-19 infection rate of household members.

Community

Lending a Helping Hand

Physician assistant studies student using 3D printing to enhance PPE during COVID-19

Leadership

From the Frontlines

Wesley Burks, M.D., dean of UNC School of Medicine, vice chancellor for medical affairs and CEO of UNC Health, shares how students, faculty and researchers are responding to the COVID-19 pandemic.

Global Impact

COVID-19 Research Heroes

Working together to combat the COVID-19 pandemic